Boston Scientific Corp. Announces FDA Approval And U.S. Launch Of PROMUS 2.25 mm Everolimus-Eluting Coronary Stent System

Join Business Exchange

to access the most relevant content for you, filtered by like-minded business professionals. Learn more

Register using your
account Register for Beta

Member sign in